BioStock: Cereno Scientific expands patent portfolio

Cereno Scientific’s patent portfolio continues to grow. This week, the biotech company announced being granted patents expanding the protection of CS1 to the European market, thus securing patent protection for its lead programme in nearly all global key markets. In addition, the company also announced that the first patent for preclinical programme CS585 has been granted by the US Patent Office.

Read the full article about Cereno Scientific at biostock.se:

https://www.biostock.se/en/2021/09/cereno-scientific-expands-patent-portfolio/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se